# HOST - DAPT Duration According the Bleeding Risk

Study · id `cardio:ct-nct05631769` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05631769](<https://clinicaltrials.gov/study/NCT05631769>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05631769

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 4900 participants.

## Technical summary

Registry record NCT05631769. Randomized; single masking; primary purpose treatment. Start 2020-07-24 (actual); primary completion 2024-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 4900 participants (planned count; ClinicalTrials.gov record NCT05631769, source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)
- Started: 2020-07-24 (actual) (ClinicalTrials.gov record NCT05631769, source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (actual) (ClinicalTrials.gov record NCT05631769, source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05631769, source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT05631769, source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05631769-2025-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: HOST - DAPT Duration According the Bleeding Risk
- Acronym: HOST-BR
- Condition: Coronary Artery Disease
- Condition: Acute Myocardial Infarction
- Condition: Stable Angina
- Intervention (Drug): Dual antiplatelet agent duration
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Hanyang University Seoul Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Hanyang University Seoul Hospital (`cardio:org-hanyang-university-seoul-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial (`cardio:pubmed-41631724`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 82b378989c204bafe73a20dda5b4e152cecdf49470139f6508f33b8afcf5e92a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
